Effects of soybean supplementation on blood glucose, plasma lipid levels, and erythrocyte antioxidant enzyme activity in type 2 diabetes mellitus patients

  • Chang, Ji-Ho (Department of Food & Nutrition, Hanyang University) ;
  • Kim, Min-Sun (Department of Food & Nutrition, Hanyang University) ;
  • Kim, Tae-Wha (Department of Internal Medicine, College of Medicine, Hanyang University Hospital) ;
  • Lee, Sang-Sun (Department of Food & Nutrition, Hanyang University)
  • Published : 2008.09.30

Abstract

The purpose of this study was to investigate the effect of soybean on blood glucose and lipid concentrations, and antioxidant enzyme activity in type 2 diabetes mellitus(DM) patients. We divided patients into two groups and fed them, respectively, a basal diet(control group) and a basal diet with 69 g/d of soybean(soybean group) for 4 weeks. Pills with roasted soybean powder were provided to the soybean supplementation group three times a day. Macronutrients intake except dietary fiber was similar between the two groups. No significant differences were observed in dietary intakes or body weight before and after the supplementation. Energy composition ratio of C:F:P was 65:19:16 in the control group, 64:20:16 in the soybean group. The blood parameters of subjects before supplementation, such as fasting blood glucose, postprandial glucose level, total cholesterol, triglyceride, LDL-cholesterol and $HbA_1C$ were not different between the two groups. After supplementation, fasting blood glucose(p<0.001), postprandial glucose level(p<0.001) and serum triglyceride level(p<0.05) were significantly reduced in the soybean group in comparison with the control group. The total cholesterol level was not significantly different between the control and the supplemented group after 4 weeks of treatment. TBARS levels of the soybean group were not significantly different from those of the control group. The activities of catalase(p<0.01) and glutathione peroxidase(p<0.05) were significantly higher in the soybean group compared to the control group. The results of this study suggest that soybean supplementation would be helpful to control blood glucose and serum lipid in diabetic patients. Also, soybean showed an antioxidant activity that may contribute to enhance the effect of antioxidant defense. This activity contributes to protection against oxidative damage in type 2 DM patients. Soybean may have potential use in the disease management of patients with DM.

Keywords

Soybean;glycemic control;blood lipid levels;antioxidant enzyme activities;type 2 DM

References

  1. Anderson JW, Johnsstone BW & Cook-Newell ME (1995). Metaanalysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282 https://doi.org/10.1056/NEJM199508033330502
  2. Coulston AM & Hollenbeck CB (1988). Source and amount of dietary carbohydrate in patients with noninsulin-dependent diabetes mellitus. Top Clin Nutr 3:17-24
  3. Holf S, Heading RC, Carter DC, Prescott LE & Tothill P (1979). Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet 1: 636-639
  4. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G & Apparao C (2001). Lipid peroxidation and antioxidant enzyme status in type 2 diabetic with coronary heart disease. Diabetes Res Clin Pract 53:33-39 https://doi.org/10.1016/S0168-8227(01)00238-8
  5. Simpson HCR, Simpson RW & Lousley S (1981). A high carbohydrate leguminous fiber diet improves all aspects of diabetic control. Lancet 1:1-5
  6. Slameron J, Manson JE, Stampfer MJ, Colditz G, Wing AL & Willett WC (1997). Dietary fiber glycemic load and risk of non-insulin dependent diabetes mellitus in women. JAMA 277:472-477 https://doi.org/10.1001/jama.277.6.472
  7. Subramanian V & Leelavinothan P (2002). Antioxidant effect of Phaseolus vulgaris in streptozotocin-induced diabetic rats. Asia Pacific J Clin Nutr 11:206-209 https://doi.org/10.1046/j.1440-6047.2002.00292.x
  8. The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development of diabetes mellitus. N Engl J Med 329:977-986 https://doi.org/10.1056/NEJM199309303291401
  9. Wild S, Roglic G & Green A (2004). Global prevalence of diabetes. Diabetes Care 27:1047-1053 https://doi.org/10.2337/diacare.27.5.1047
  10. McColl AJ, Kong C, Nimmo L, Collins J, Elkeles RS & Richmond W (1997). Total antioxidant status, protein glycation, lipid hydroperoxides in non insulin dependent diabetes mellitus. Biochem Soc Trans 25:S660 https://doi.org/10.1042/bst025s660
  11. Grace SL, Andrew PG, Angelita L, John JG, Carl A & Gustav S (1986). Soy fiber improves lipid and carbohydrate metabolism in primary hyperlipidemic subjects. Atherosclerosis 62:239-248 https://doi.org/10.1016/0021-9150(86)90098-5
  12. Lee YK, Lee HS & Kim BW (1994). Dietary fiber intake in subject with non-insulin dependent diabetes mellitus. Diabetes 1:256-262
  13. Flohe L & Gunzler W (1984). Assays of glutathione peroxidase. In: Methods in enzymology, vol.105, p.114-121. Academic Press, New York. USA
  14. Kurowska EM, Jordan J & Spence JD (1997). Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects. Clin Invest Med 20:162-170
  15. McCord JM, Keele BB & Fridovich I (1971). An enzyme based theory of obligate anaerobiosis : The physiological functions of superoxide dismutase. Proc Natl Acad Sci USA 68:1024-1027
  16. Zacharia M (1983). Effect of brown rice and soybean dietary fiber on the control of glucose and lipid metabolism in diabetic rats. Am J Clin Nutr 38:388-393 https://doi.org/10.1093/ajcn/38.3.388
  17. Kim EM, Rah MY, Park MS & Baik HJ (1999). Guidelines for clinical nutrition management. p.180-216. The Korean Dietetic Association, Seoul. Republic of Korea
  18. Kjeld H, Marius C, Mette S, Birgitte B & Lars H (2001). Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24:228-233 https://doi.org/10.2337/diacare.24.2.228
  19. Hermansen K, Sondergraad M, Hoie L, Carstensen M & Brock B (2001). Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes care 24:228-233 https://doi.org/10.2337/diacare.24.2.228
  20. Anderson JW, Chen W-JL & Sieling B (1980). Hypolipidemic effect of high-carbohydrate, high-fiber diets. Metabolism 29:551-558 https://doi.org/10.1016/0026-0495(80)90081-5
  21. Anderson JW, Randles KM, Kendall DW & Jenkins DJ (2004). Carbohydrate and fiber recommendations for individuals with diabetes a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 23:5-17 https://doi.org/10.1080/07315724.2004.10719338
  22. Kang MJ, Kim JI, Yoon SY, Kim JC & Cha IJ (2006). Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. J Med Food 9:182-186 https://doi.org/10.1089/jmf.2006.9.182
  23. Alan CT, Arthur IV & Grace SL (1987). Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagons, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr 45:596-601 https://doi.org/10.1093/ajcn/45.3.596
  24. Tonstard S, Smerud K & Hoie L (2002). A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76:78-84 https://doi.org/10.1093/ajcn/76.1.78
  25. Chance B, Greenstein DS & Roughton FJ (1952). The mechanism of catalase action 1 - steady state analysis. Arch Biochem Biophys 37:301-321 https://doi.org/10.1016/0003-9861(52)90194-X
  26. Jenkins DJA, Wolever TMS & Taylor RH (1981). Glycemic index of foods:a physiological basis for carbohydrate exchange. Am J Clin Nutr 34:362-366 https://doi.org/10.1093/ajcn/34.3.362
  27. Mahoney JJ, Verman HJ, Stevenson DK & Van Vessel AL (1993). Measurements of carboxyhaemoglobin by five spectrophotometers (cooximeters) in comparison with reference methods. Clin Chem 39:1693-1700
  28. Palanduz S, Ademoglu E, Gokkusu C & Tamer S (2001). Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol 109:309-318
  29. Aebi HE (1984). Catalase. In: Methods of enzymatic analysis; vol.3, p.273-285. Verlag Chemie CMBH, Weinheim. Germany
  30. Food and Drug Administration (1999). Food labeling, health claimms, soy proteins, and coronary heart disease. Fed Regist 57:699-733
  31. Hunt JV, Dean RT & Wolff SP (1988). Hydroxyl radical production and autooxidative glycosylation. Glucose autooxidation as the cause of protein damage in the experimental glycation model of diabetes and aging. Biochem J 256:205-212 https://doi.org/10.1042/bj2560205
  32. Lee JS (2006). Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocininduced diabetic rats. Life Sci 79:1578-1584 https://doi.org/10.1016/j.lfs.2006.06.030
  33. Min HK & Huh KB (1992). Clinical characteristics of diabetes in Korea. Diabetes 16:163-174
  34. Kumuhekar HM & Katyane SS (1992). Altered kinetic attributes of $Na^+-K^+$ ATPase activity in kidney, brain and erythrocyte membrane in alloxan diabetic rats. Indian J Exp Biol 30:26-32
  35. Marklund S (1984). Pyrogallol autoxidation. In: CRC handbook of methods for oxygen radical research, p.243. CRC Press Inc., Boca Raton, FL. USA
  36. Polichetti E, Diaconesku N, De La Porte PL, Malli L, Portugal H & Pauli AM (1996). Cholesterol-lowering effect of soybean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion. Br J Nutr 75:471-478 https://doi.org/10.1079/BJN19960148
  37. Venkateswaran S & Pari L (2002). Antioxidant effect of Phaseolus vulgaris on streptozotocin-induced diabetic rats. Asia Pacific J Clin Nutr 11:206-209 https://doi.org/10.1046/j.1440-6047.2002.00292.x